Pharmacist Follow-up, a Qualitative Study of Patient Experience

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01131715
Recruitment Status : Unknown
Verified May 2010 by Hospital Pharmacy of North Norway Trust.
Recruitment status was:  Active, not recruiting
First Posted : May 27, 2010
Last Update Posted : May 27, 2010
University of Tromso
Information provided by:
Hospital Pharmacy of North Norway Trust

Brief Summary:
A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Condition or disease
Patient Satisfaction Patient Preference

Study Type : Observational
Actual Enrollment : 4 participants
Official Title: Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.
Study Start Date : March 2010
Estimated Primary Completion Date : July 2010
Estimated Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Diseases
U.S. FDA Resources

Study group
Patients who are included in the pharmacist follow-up procedure

Primary Outcome Measures :
  1. Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients [ Time Frame: 3 months or 1 year ]
    In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients' experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings. Outcomes will be presented as overall themes touched by the informants.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients included in the study "Pharmacist follow-up of patients with CHD".

Inclusion Criteria:

  • must have met the pharmacist at least twice
  • living within the area of Tromsoe city so that interviews are possible

Exclusion Criteria

  • none as patients are already enrolled in another study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01131715

University of Tromsoe
Tromso, Norway, 9037
Sponsors and Collaborators
Hospital Pharmacy of North Norway Trust
University of Tromso
Principal Investigator: Lars Smaabrekke, PhD University of Tromso
Study Chair: Beate H Garcia, PhDstudent Hospital Pharmacy of North Norway Trust

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Lars Smaabrekke, University of Tromsø Identifier: NCT01131715     History of Changes
Other Study ID Numbers: SHAN-002
First Posted: May 27, 2010    Key Record Dates
Last Update Posted: May 27, 2010
Last Verified: May 2010

Keywords provided by Hospital Pharmacy of North Norway Trust:
Qualitetive interview
Coronary heart disease (CHD)
Patient experience
Patient perception

Additional relevant MeSH terms:
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Arterial Occlusive Diseases